Skip to main content
. 2019 Oct 1;17:66. doi: 10.1186/s12969-019-0345-2

Table 5.

Change in structural complication between baseline and 6-months follow-up. Change in structural complication within the 6 months follow-up

Baseline 3-months follow-up 6-months follow-up
Changes in structural complications between baseline and 3-months follow-up Changes in structural complications between baseline and 6-months follow-up
(n = 103 eyes) (n = 103 eyes) (n = 103 eyes)
total total newly reported no longer reported total newly reported no longer reported
N % N % N % N % N % N % N %
Any structural complication 64 62.8 61 61.6 64 62.1
Ocular hypotony (IOP ≤ 6 mmHg) during the last 3 months 3 2.9 3 2.9 1 1.0 1 1.0 0 0.0 0 0.0 3 2.9
Ocular hypertension (IOP ≥ 21 mmHg) during the last 3 months 6 5.8 6 5.8 2 1.9 2 1.9 4 3.9 1 1.0 3 2.9
Posterior synechiae formation 50 48.5 51 49.5 1 1.0 0 0.0 53 51.5 3 2.9 0 0.0
Glaucoma 4 3.9 3 2.9 0 0.0 1 1.0 5 4.9 1 1.0 0 0.0
Cataract 18 17.5 17 16.5 2 1.9 3 2.9 24 23.3 6 5.8 0 0.0
Band keratopathy in the cornea 25 24.3 25 24.3 2 1.9 2 1.9 26 22.9 2 1.9 0 0.0
Optic disc edema 10 9.7 6 5.8 0 0.0 4 3.9 3 2.9 0 0.0 7 6.8
Macular edema 10 9.7 5 4.9 2 1.9 7 6.8 3 2.9 1 1.0 8 7.8
Epiretinal membrane formation 5 4.9 5 4.9 0 0.0 0 0.0 5 4.9 0 0.0 0 0.0
Vitreous haze 14 13.6 13 12.6 4 3.9 5 4.9 13 12.6 5 4.9 6 5.8